Regorafenib 755037-03-7 wiki
Regorafenib | C21H15ClF4N4O3 | CID 11167602 - PubChem
Regorafenib - wikidoc
O2k-Publications: CIV - Bioblast
Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors | Nature Communications
JPM | Free Full-Text | Promoting Precision Cancer Medicine through a Community-Driven Knowledgebase
Regorafenib | C21H15ClF4N4O3 | CID 11167602 - PubChem
Regorafenib Impurity 10 2098799-12-1 wiki
Regorafenib | C21H15ClF4N4O3 | CID 11167602 - PubChem
Role of Tyrosine Kinase in cancer | PPT
Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma | Future Oncology
Regorafenib metabolite M4 | C20H13ClF4N4O3 | CID 53491672 - PubChem
Regorafenib: Uses, Interactions, Mechanism of Action | DrugBank Online
O2k-Publications: Cancer - Bioblast
Trifluridine/tipiracil: A practical guide to its use in the management of refractory metastatic colorectal cancer in Australia - Price - 2020 - Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
Regorafenib 755037-03-7 wiki
New Drug Approvals 2012 - Pt. XXI - Regorafenib (Stivarga®)
Rifampicin 13292-46-1 wiki
REGORAFENIB ANHYDROUS
Glucocorticoid-induced microRNA-378 signaling mediates the progression of pancreatic cancer by enhancing autophagy | Cell Death & Disease
Regorafenib 755037-03-7 wiki
JPM | Free Full-Text | Promoting Precision Cancer Medicine through a Community-Driven Knowledgebase
Regorafenib | C21H15ClF4N4O3 | CID 11167602 - PubChem
Regorafenib | C21H15ClF4N4O3 | CID 11167602 - PubChem
Regorafenib | C21H15ClF4N4O3 | CID 11167602 - PubChem
New Drug Approvals 2012 - Pt. XXI - Regorafenib (Stivarga®)
Regorafenib 755037-03-7 wiki
